Table 1:

Treatment times and clinical outcomes by study

Study	Treatment	No. of Patients	OTP (min)	PTR (min)	Final TICI 2b/3 (%)	90-Day mRS ≤2 (%)	90-Day Mortality (%)	Asp Only (%)	Asp + Adjuvant (%)
Mocco et al,¹³ 2016	Asp only	50	227	NA	70 (30/43)	38	12	NA	NA
Park et al,¹⁰ 2016	Asp only	32	234	33	84	78	3	NA	NA
Eom et al,⁷ 2014	Asp only	32	281	76	88	NA	25	NA	NA
Hwang et al,⁸ 2013	Asp only	20	276	63	65	45	0	NA	NA
Kang et al,¹¹ 2013 (period 1)	Asp only	61	292	60	74	49	NA	NA	NA
Delgado Almandoz et al,¹⁵ 2016	ADAPT	45	224	50	89	56	18	NA	NA
Hungerford et al,¹⁶ 2016	ADAPT	154	454	40	95	53	10	81	19
Kabbasch et al,¹⁸ 2016	ADAPT	30	189	26	90	43	20	70	30
Kim et al,²⁰ 2016	ADAPT	25	236	53	72	84	0	81	19
Kowoll et al,²¹ 2016	ADAPT	54	179	41	93	NA	NA	56	44
Lapergue et al,²² 2016	ADAPT	124	247	45	82	53	23	55	45
Mascitelli et al,²⁷ 2016	ADAPT	76	295	NA	92	NA	NA	58	42
Romano et al,²³ 2016	ADAPT	152	227	58	76	51	8	63	29
Vargas et al,²⁶ 2016	ADAPT	191	468	37	94	54	15	76	23
Jankowitz et al,¹⁷ 2015	ADAPT	112	267	70	86	46	31	59	41
Kim et al,⁹ 2015	ADAPT	70	238	34	91	60	3	91	9
Turk et al,²⁴ 2014a	ADAPT	98	507	37	95	39	19	78	22
Turk et al,²⁵ 2014b	ADAPT	64	NA	NA	95	47	NA	NA	NA
Turk et al,¹² 2014c	ADAPT	37	342	28	97	NA	NA	76	24
Kang et al,¹¹ 2013 (period 2)	ADAPT	74	233	68	85	68	NA	NA	NA
Kang et al,¹⁹ 2011	ADAPT	22	318	40	82	46	14	82	18

Note:—Asp indicates aspiration; NA, not available; OTP, onset-to-puncture; PTR, puncture-to-recanalization.